国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2010年
3期
267-270
,共4页
骨质疏松症%活血化瘀药%研究进展
骨質疏鬆癥%活血化瘀藥%研究進展
골질소송증%활혈화어약%연구진전
Osteoporosis%Single Chinese medicine for activating blood and dissolving stasis%Research progress
近年来的中药药理学研究发现,活血化瘀药中的骨碎补、牛膝、丹参和三七有抗骨质疏松作用,能提高骨矿密度和骨矿总量,促进骨形成,减少骨吸收.兹将国内外近年来的研究现状进行了整理分析,以期为骨质疏松症的防治提供用药思路与方法.
近年來的中藥藥理學研究髮現,活血化瘀藥中的骨碎補、牛膝、丹參和三七有抗骨質疏鬆作用,能提高骨礦密度和骨礦總量,促進骨形成,減少骨吸收.玆將國內外近年來的研究現狀進行瞭整理分析,以期為骨質疏鬆癥的防治提供用藥思路與方法.
근년래적중약약이학연구발현,활혈화어약중적골쇄보、우슬、단삼화삼칠유항골질소송작용,능제고골광밀도화골광총량,촉진골형성,감소골흡수.자장국내외근년래적연구현상진행료정리분석,이기위골질소송증적방치제공용약사로여방법.
In recent years,pharmacological researches of Chinese medicine found that the single Chinese medicines of activating blood and dissolving stasis,such as Drynaria and Bidentata and Salvia and Panax notoginseng had very good effects of resisting osteoporosis,significantly improving bone mineral density(BMD)and bone mineral content(BMC),promoting bone formation,and preventing bone absorption.Based on the documentations from home and abroad,the overview had analyzed the current situation for providing new ideas and methods of osteoporosis prevention and treatment.